Test Price
9,100 AED✅ Home Collection Available
Whole Exome Sequencing Trio Test in UAE | 9100 AED | 2026 DHA Guidelines
تحليل تسلسل الإكسوم الكامل الثلاثي (WES Trio) في الإمارات | 9100 درهم | معتمد من هيئة الصحة بدبي
Executive Summary – UAE’s Most Advanced Trio Whole Exome Sequencing
This Whole Exome Sequencing Trio test, priced at 9100 AED, delivers a comprehensive genetic analysis of the proband and both parents using Genetic Testing under Federal Decree‑Law No. 41 of 2024.
يقدم اختبار تسلسل الإكسوم الكامل الثلاثي هذا، بسعر 9100 درهم، تحليلاً جينياً شاملاً للمريض والوالدين باستخدام تقنية التسلسل من الجيل التالي (NGS) في مختبراتنا الحاصلة على شهادة ISO 9001:2015. مع حساسية تشخيصية تصل إلى 99.9%، وخدمة سحب الدم المنزلي الممتازة مع نقل مبرد، وإرشادات ما بعد الفحص السريري تحت إشراف الدكتور برابهاكار ريدي (ترخيص هيئة الصحة بدبي: 61713011)، نضمن فحوصات جينية دقيقة وسرية ومتوافقة مع القانون الاتحادي رقم 41 لعام 2024.
- Premium Logistics: Paid Hospital‑Grade Home Collection via ISO Certified Cold‑Chain (8 AM – 11 PM)
- Clinical Guidance: Telephonic Post‑Test Result Interpretation & Genetic Counseling Support
- Insurance: Direct Billing Verification via WhatsApp +971 54 548 8731
Test Overview
Whole Exome Sequencing Trio simultaneously examines the protein‑coding regions (exome) of a child and both biological parents to identify hereditary disease‑causing genetic variants with unmatched precision. This trio approach drastically improves the detection of de novo mutations and recessive disorders compared to proband‑only testing, delivering a definitive molecular diagnosis for complex genetic conditions.
يقوم اختبار تسلسل الإكسوم الكامل الثلاثي بفحص المناطق المشفرة للبروتين (الإكسوم) للطفل وكلا الوالدين البيولوجيين في آنٍ واحد، مما يعزز بشكل كبير كشف الطفرات الجديدة والاضطرابات المتنحية، ويوفر تشخيصًا جزيئيًا دقيقًا للحالات الوراثية المعقدة.
| Feature | Our Trio WES Test | Proband‑Only WES (Alternative) |
|---|---|---|
| Methodology | NGS Whole Exome Sequencing with trio analysis (proband + parents) | NGS Whole Exome Sequencing of the affected individual only |
| Diagnostic Yield | Up to 35–40% in undiagnosed genetic disorders; high sensitivity for de novo & recessive variants | ~25–30%; misses parental segregation and de novo confirmation |
| Turnaround Time | 6 Weeks | 6–8 Weeks (often similar) |
| Clinical Utility | Comprehensive – facilitates accurate genetic counseling, recurrence risk assessment, and family planning | Limited – may require additional parental testing later, delaying diagnosis |
| Price | 9100 AED | ~6500–7500 AED (proband only) |
Physician Insight & Safety Protocol
Dr. PRABHAKAR REDDY, DHA‑Licensed Clinical Geneticist (License: 61713011)
“Whole exome sequencing trio is a transformative diagnostic tool, but it must always be interpreted within the full clinical and family history context. Every variant of uncertain significance requires careful segregation analysis and dedicated genetic counseling. I strongly urge patients to review results with their referring physician and a qualified genetic counselor before making any medical decisions.”
⚠️ Medication Warning: Do not discontinue or alter any prescribed medication based on this genetic test result without explicit consultation with your treating doctor.
🔴 Exclusion Criteria & Emergency Red Flags
- Exclusion Criteria: This test is not indicated for persons under 18 without parental/legal guardian consent (per UAE CDS Law 2026). It is not validated for somatic mutation profiling in malignancies or for stand‑alone prenatal diagnosis without genetic counseling.
- Red Flags – Seek Immediate Medical Attention: If the proband or a family member experiences new‑onset seizures, severe neurological deterioration, loss of consciousness, or acute unexplained symptoms, go to the nearest emergency department. Genetic testing results should never delay urgent clinical care.
Patient FAQ & Clinical Guidance
1. What is the whole exome sequencing trio test and why is it done?
Direct Answer: Whole exome sequencing trio simultaneously analyzes all protein-coding genes of the proband and both parents to identify hereditary disease-causing mutations. This powerful approach compares the child’s genetic code with that of the biological parents, pinpointing spontaneous (de novo) changes or inherited recessive variants that may explain a wide range of genetic disorders, from neurodevelopmental delays to metabolic syndromes. A pre‑test genetic counseling session is strongly recommended.
يقوم اختبار تسلسل الإكسوم الكامل الثلاثي بتحليل جميع الجينات المشفرة للبروتين لدى المريض وكلا الوالدين في آنٍ واحد لتحديد الطفرات المسببة للأمراض الوراثية. يقارن هذا النهج الشفرة الوراثية للطفل مع الوالدين البيولوجيين، مما يكشف عن التغيرات الجديدة أو المتنحية الموروثة.
2. How is the sample collected and what is the turnaround time?
Direct Answer: A simple blood draw from the child and both parents yields DNA for sequencing, with results delivered in 6 weeks. Our trained phlebotomists perform a comfortable home or clinic‑based collection using EDTA tubes, all transported under strict cold‑chain protocols. Once the sample arrives at the ISO‑certified lab, the entire exome is captured, sequenced, and bioinformatically analyzed with trio comparison.
يتم جمع عينة دم بسيطة من الطفل وكلا الوالدين للحصول على الحمض النووي، وتُصدر النتائج خلال 6 أسابيع. يقوم أخصائيو سحب الدم المدرّبون بجمع العينة في المنزل أو العيادة باستخدام أنابيب EDTA، مع النقل وفق بروتوكولات التبريد الصارمة.
3. Is the test covered by insurance and what is the cost?
Direct Answer: Our test costs 9100 AED, with free insurance verification and direct billing via WhatsApp +971 54 548 8731. Many UAE insurers cover whole exome sequencing when medically indicated; our dedicated support team handles prior approvals and direct billing to most major networks. You can simply share your insurance card copy through WhatsApp, and we will confirm eligibility before sample collection.
تبلغ تكلفة اختبارنا 9100 درهم، مع خدمة التحقق المجاني من التأمين والفوترة المباشرة عبر واتساب على الرقم +971 54 548 8731. تغطي العديد من شركات التأمين في الإمارات اختبار تسلسل الإكسوم الكامل عند وجود دواعٍ طبية.
🔒 UAE Legal & Regulatory Compliance: All procedures adhere to Federal Decree‑Law No. 41 of 2024 (Article 87) on Genetic Testing, the UAE Patient Data Privacy Law (PDPL), and CDS Law 2026 for minor consent. Our facility is licensed by the Dubai Health Authority (Facility License: 9834453) and operates under ISO 9001:2015 Certified Quality Management (Cert: INT/EGQ/2509DA/3139).
Clinical Methodology: Next Generation Sequencing (NGS) – Whole Exome Sequencing (WES) with trio analysis. LOINC code: 93882-7. Associated 2026 ICD‑10‑CM codes: Z13.79 (Encounter for screening for genetic disorders), Z84.81 (Family history of carrier of genetic disease), Z15.89 (Genetic susceptibility to other specified conditions).
Pre‑ Requirement: Duly filled Whole Exome Sequencing Trio Consent Form (Form 43) is mandatory.
دعم ثنائي اللغة متاح
التحقق من التغطية التأمينية
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
توقف عن التخمين. أرسل صورة من بطاقة التأمين ووصفة الطبيب إلى فريق التحقق المعتمد من هيئة الصحة بدبي عبر الواتساب. احصل على تحديث الحالة في دقائق.
Available in Arabic, English, Hindi & Urdu
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians